In addition, the inhibition of the NFKB1 and NFKB2 genes shows a decrease in the inflammatory process, consequently improving hypertension and suppressing vasoconstriction induced by diabetes (Gautam et al., 2017; Behera et al., 2020). The gene discussed is NFKB1; the disease is Hypertension.